Search Within

Sean Matthew McBride

Formats
  1. Meeting Abstract (159)
  2. Journal Article (113)
  3. Review (6)
  4. Correspondence (4)
  5. Editorial (4)
  6. Guidelines (4)
  7. Book Section (3)
Groups
  1. Radiation Oncology, Department of (293)
  2. Survivorship Research (192)
  3. Department of Medicine (144)
  4. Solid Tumor Oncology Division (144)
  5. Head and Neck Service (125)
  6. Surgery (122)

More Groups

People
  1. Nancy Lee (169)
  2. Nadeem Riaz (148)
  3. Chiaojung Jillian Tsai (110)
  4. Eric Sherman (108)
  5. Richard Wong (72)
  6. Marisa Kollmeier (60)

More People

Years
  1. 2025 (7)
  2. 2024 (27)
  3. 2023 (18)
  4. 2022 (26)
  5. 2021 (29)
  6. 2020 (33)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (113)
  2. Journal of Clinical Oncology (39)
  3. Head & Neck (11)
  4. Advances in Radiation Oncology (9)
  5. Cancer (7)
  6. Oral Oncology (7)

More Publications

Publishers
  1. Elsevier Inc. (144)
  2. American Society of Clinical Oncology (42)
  3. Wiley Blackwell (20)
  4. Elsevier Science, Inc. (18)
  5. John Wiley & Sons, Inc. (11)
  6. American Medical Association (10)

More Publishers

Results (293)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801). A randomized phase 3 double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation
    Meeting Abstract

    McBride, S. M.; Niazi, T.; Williams, S.; Davis, I. D.; Stockler, M. R.; Martin, A. J.; Bracken, K.; Roncolato, F. T.; Horvath, L.; Sengupta, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity
    Journal Article

    Teyateeti, A.; Grossman, C.; Kollmeier, M. A.; Fiasconaro, M.; Hopkins, M.; McBride, S.; Gorovets, D.; Shasha, D.; Cohen, G.; Zhang, Z.; more...
    BJU International (2022)

    Fulltext@MSK | Save
  • Dermatological adverse events in prostate cancer patients treated with the androgen receptor inhibitor apalutamide
    Journal Article

    Pan, A.; Reingold, R. E.; Zhao, J. L.; Moy, A.; Kraehenbuehl, L.; Dranitsaris, G.; McBride, S. M.; Scher, H. I.; Kollmeier, M. A.; Xiao, H.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • A patient-level data meta-analysis of the abscopal effect
    Review

    Hatten, S. J. Jr; Lehrer, E. J.; Liao, J.; Sha, C. M.; Trifiletti, D. M.; Siva, S.; McBride, S. M.; Palma, D.; Holder, S. L.; Zaorsky, N. G.
    Advances in Radiation Oncology (2022)

    Fulltext@MSK | Save
  • Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirusā€“associated oropharyngeal carcinoma treated with definitive chemoradiotherapy
    Journal Article

    Tsai, C. J.; McBride, S. M.; Riaz, N.; Kang, J. J.; Spielsinger, D. J.; Waldenberg, T.; Gelblum, D.; Yu, Y.; Chen, L. C.; Zakeri, K.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Dosimetric comparison of intensity modulated radiotherapy (IMRT) and intensity modulated proton therapy (IMPT) for novel oral tongue avoidance concept in low-risk squamous cell carcinoma of the oral tongue
    Meeting Abstract

    Press, R. H.; Hu, L.; Huang, S.; Hasan, S.; Choi, I. J.; Simone, C. B. 2nd; Chhabra, A. M.; Gelblum, D.; Kabarriti, R.; Sharma, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Peer review of head and neck cancer planning target volumes in radiation oncology
    Journal Article

    Hesse, J.; Chen, L.; Yu, Y.; Kang, J. J.; Riaz, N.; Tsai, C. J.; McBride, S. M.; Gelblum, D.; Zakeri, K.; Lee, N. Y.
    Advances in Radiation Oncology (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; SchoĢˆder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer
    Journal Article

    Gorovets, D.; Hopkins, M.; Kollmeier, M.; Moore, A.; Goel, A.; Shasha, D.; Brennan, V.; McBride, S.; Cohen, G.; Damato, A. L.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save